A detailed history of Bank Of Jackson Hole Trust transactions in Repligen Corp stock. As of the latest transaction made, Bank Of Jackson Hole Trust holds 17 shares of RGEN stock, worth $2,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Holding current value
$2,825
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$123.41 - $160.92 $2,097 - $2,735
17 New
17 $2.45 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.22B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Bank Of Jackson Hole Trust Portfolio

Follow Bank Of Jackson Hole Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Jackson Hole Trust, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Jackson Hole Trust with notifications on news.